4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-16-140127
Director sold 48,375 shares at an average $18.15 ($878,106)
- Director acquired 48,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZASLOFF MICHAEL A Director | 2016-08-12 | Option exercise | +10,381 | $15.23 | $158,103 | 42,792 | D |
| ZASLOFF MICHAEL A Director | 2016-08-12 | Option exercise | +20,594 | $14.23 | $293,053 | 63,386 | D |
| ZASLOFF MICHAEL A Director | 2016-08-12 | Sale | −30,975 | $18.12 | $561,134 | 32,411 | D |
| ZASLOFF MICHAEL A Director | 2016-08-15 | Option exercise | +17,400 | $14.23 | $247,602 | 49,811 | D |
| ZASLOFF MICHAEL A Director | 2016-08-15 | Sale | −17,400 | $18.22 | $316,972 | 32,411 | D |
| Derivatives | |||||||
| ZASLOFF MICHAEL A Director | 2016-08-12 | Option exercise · Stock Option (right to buy) | −10,381 | 0 | D | ||
| ZASLOFF MICHAEL A Director | 2016-08-12 | Option exercise · Stock Option (right to buy) | −20,594 | 17,400 | D | ||
| ZASLOFF MICHAEL A Director | 2016-08-15 | Option exercise · Stock Option (right to buy) | −17,400 | 0 | D | ||
| Open-market sales · 48,375 sh · avg $18.15 · $878,106 | |||||||
Loading xslF345X03/a4.xml…